Compounds inhibiting GTPases
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT06075810
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 9, 2023
Completion: Oct 31, 2025
Loading map...